BTPNF yields 25317.05% · PFE yields 6.13%● Live data
📍 BTPNF pulled ahead of the other in Year 1
Combined, BTPNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BTPNF + PFE for your $10,000?
PT Bank BTPN Tbk provides various banking products and services primarily in Indonesia. It operates through five segments: Retail; Micro, Small & Medium Enterprises; Funding and Treasury; Corporate; and Sharia. The company offers savings and current account; term, flexi, and time deposits; and working capital and investment, bilateral and syndication, term, demand, green, pension, active employee, and student Loan; sustainability linked loan project/structured financing, overdraft, asset-based and rural bank financing, and supply chain financing; and credit cards. It also provides bancassurance and investment products, such as mutual fund and government bonds; Sharia banking services; import LC issuance/ import bill negotiation, export LC advising/confirmation/export bill collection, documentary collection, trust receipt/trade loan, structured trade finance, receivable purchase, and bank guarantee services; and liquidity management, internet and mobile banking, and collections payment services. In addition, the company offers treasury services, such as foreign exchange, derivatives, money market, and fixed income. As of December 31, 2021, it operated 82 branches, 349 subbranches, 224 and ATMs and TCRs. The company was founded in 1958 and is headquartered in Jakarta, Indonesia. PT Bank BTPN Tbk operates as a subsidiary of Sumitomo Mitsui Banking Corporation.
Full BTPNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.